Flagship Ventures Fund 2007, L.P.'s Net Worth

$74 Million

Who is Flagship Ventures Fund 2007, L.P.?

Flagship Ventures Fund 2007, L.P. has an estimated net worth of $74 Million. This is based on reported shares across multiple companies, which include Kaleido Biosciences, Inc., Seres Therapeutics, Inc., TransMedics Group, Inc., Eleven Biotherapeutics, Inc., Axcella Health Inc., TETRAPHASE PHARMACEUTICALS INC, AGIOS PHARMACEUTICALS INC, BG Medicine, Inc., Receptos, Inc., and SELECTA BIOSCIENCES INC.

SEC CIK

Flagship Ventures Fund 2007, L.P.'s CIK is 0001508052

Past Insider Trading and Trends

2014 was Flagship Ventures Fund 2007, L.P.'s most active year for acquiring shares with 6 total transactions. Flagship Ventures Fund 2007, L.P.'s most active month to acquire stocks was the month of January. 2013 was Flagship Ventures Fund 2007, L.P.'s most active year for disposing of shares, totalling 8 transactions. Flagship Ventures Fund 2007, L.P.'s most active month to dispose stocks was the month of January. 2013 saw Flagship Ventures Fund 2007, L.P. paying a total of $11,806,441.04 for 5,670,792 shares, this is the most they've acquired in one year. In 2013 Flagship Ventures Fund 2007, L.P. cashed out on 23,619,659 shares for a total of $5,712,759.89, their largest year based on trade value.